Should you buy Nano-X Imaging stock now?
No, the technical signal for Nano-X Imaging is currently SELL. Nano-X Imaging trades at $0.99 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -0.097 with rising momentum (signal: -0.129); RSI is at 42.4 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $5.13 points to 416.4% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Nano-X Imaging stock?
The average analyst price target for Nano-X Imaging is $5.13. The current price is $0.99, which gives an upside of 416.4%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $4.62 and $5.64.
Is Nano-X Imaging a dividend stock?
No, Nano-X Imaging does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Nano-X Imaging stock?
Nano-X Imaging is rated as a stock with extreme risk. the annual standard deviation is 94.5%, which classifies the stock as extreme risk.
Is Nano-X Imaging overvalued?
No, Nano-X Imaging is considered undervalued based on the analyst price target (416.4% upside). Nano-X Imaging has the following valuation ratios: a P/S ratio of 5.1, a P/B ratio of 0.5. The analyst price target suggests that the stock is undervalued by 416.4%.
Is Nano-X Imaging overbought?
No, Nano-X Imaging is not overbought. RSI is at 42.4 (neutral zone). The technical indicators show: RSI is at 42.4 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 2.4% below the 20-day average (short-term downtrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Nano-X Imaging earnings report?
Nano-X Imaging reports its next earnings on August 11, 2026. The stock currently trades at $0.99.
Is Nano-X Imaging shorted?
Yes, Nano-X Imaging is shorted with 10.4% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying Nano-X Imaging stock?
Yes, insiders are net buyers of Nano-X Imaging – they are buying more shares than they are selling. Over the last 3 months, insiders have made 3 purchases and 2 sales. On a net basis, 84,945 $ worth of shares were bought. Across the last 6 reported transactions, the split is 4 purchases and 2 sales, with a net 88,595 $ bought. Active buyers include Kainan Noga, Suesskind Dan S, Meltzer Erez and others. Insider buying is generally seen as a positive signal, because management is putting its own money into the company.
Is Nano-X Imaging a good stock?
Based on our total score, Nano-X Imaging is rated as a disastrous stock with a total score of 19 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 38/100, Quality: 16/100, Momentum: 2/100. In addition: analysts see 416.4% upside to the price target; technical signal: Strong Sell. Whether Nano-X Imaging is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Nano-X Imaging stock?
The outlook for Nano-X Imaging based on current data: the average analyst price target is $5.13 (+416.4%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 8/11/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Nano-X Imaging stock falling?
Nano-X Imaging is falling right now. The technical indicators show: the price is 2.4% below the 20-day average; short interest is 10.4% (high – many are betting on a decline); insiders have mostly been buying the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Nano-X Imaging go?
The average analyst price target for Nano-X Imaging is $5.13, which corresponds to a potential gain of 416.4% from the current price of $0.99. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Nano-X Imaging fall?
We lack enough history to give a specific floor for Nano-X Imaging. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Nano-X Imaging do?
nnox.us laver medicinsk billeddannelse, hvor de især er kendt for deres digitale røntgenkilde. De har udviklet et tomografisk scanningsapparat, Nanox.ARC, som bruger den her digitale teknologi. Deres forretning handler også om at drive en platform, Nanox.CLOUD, der forbinder h... The company belongs to the Sundhed sector, more specifically the Medicinprodukter industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Nano-X Imaging as an investment.
Did Nano-X Imaging raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Nano-X Imaging. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Nano-X Imaging making money or losing money?
We have no current profitability data for Nano-X Imaging. See the latest report in the earnings history above.
Can Nano-X Imaging go bankrupt?
The bankruptcy risk of Nano-X Imaging is rated as elevated. Altman Z2 (a model for assessing financial distress) is -4.65 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 3 — which is weak. Debt relative to equity is 11% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Nano-X Imaging have a lot of debt?
No, Nano-X Imaging has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 11%. For the sundhed sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
